« Alpha-1 solving crimes in Boston | Main | I can write a better book than that! »

Baxter and Kamada strike a deal

MIAMI – The Alpha-1 Foundation this week congratulated Baxter International and Kamada Ltd. on their new agreement for the distribution and manufacture of Kamada’s intravenous alpha-1 antitrypsin product Glassia for treatment of Alpha-1 Antitrypsin Deficiency.

via www.alpha-1foundation.org

The Foundation "is hopeful that this agreement will provide an opportunity for much closer cooperation with the Alpha-1 community."

August 27, 2010 in Alpha-1, Alpha-1 Antitrypsin Deficiency, breathing problem, Bronchitis, COPD, Emphysema, Health, lung disease, Marketing, short of breath |

Comments

AlphaMale

My Photo

About

What's Alpha-1?

  • What's Alpha-1? And who cares?
    Nobody cares. No reason you should. Unless... * You get short of breath easily. * You have asthma. * You get a lot of colds, and they always seem to be worse than other people's and stay around longer. * You have COPD (emphysema, chronic bronchitis, whatever your doctor calls it). * You have liver disease and you were never a heavy drinker. * Somebody you love has these symptoms. In that case, you need more information. It can make a huge difference in your health. It might even save your life. You can check the links in these posts for lots more information. You can also email me; see the link above.

Recent Posts

Subscribe to this blog's feed

Technorati

  • Technorati
    http://
Blog powered by Typepad
Member since 09/2005

Archives

More...